but muh cdc just said 'no treatment'
—
'The clinical test carried out on 24 patients of the Marseille IHU with hydroxychloroquine would be effective against the coronavirus according to first results presented by Professor Raoult'
Professor Didier Raoult, director of the IHU in Marseille, presented the first results of the clinical test with hydroxychloroquine carried out on 24 patients affected by the coronavirus.
According to the first elements, treatment with hydroxychloroquine would reduce the load, and the results are even more promising with hydroxychloroquine and Azithromycin, an antibiotic effective against viruses.
According to him, the reduction of the viral load is central in the fight against the coronavirus, he militates so that more screenings are carried out in France.
The government will extend this test to other hospitals to test its effectiveness on a larger scale.
Encouraging results. The director of the IHU of Marseille , Professor Didier Raoult, presented Monday evening during a monthly update with the caregivers of the institute the first results of his clinical test with hydroxychloroquine against the coronavirus , a test validated by the Ministry of Health . The monthly update was featured in an eighteen-minute video posted on YouTube by the IHU.
“We were able to compare the negativation of viral carriage in patients who followed the protocol, with patients from Avignon and Nice who did not receive the treatment. Those who have not received Plaquenil [a drug based on hydroxychloroquine] are still 90% carriers of the virus after six days, while 25% are positive for those who received treatment ”, introduced the professor.
"The length of the viral port is an essential element"
But he went even further. “We, and others, have been advised for a long time to give an antibiotic in viral respiratory infections, because they are mainly complicated by pneumonia. So all the people who had clinical signs that could progress to a bacterial complication of pneumonia, they were given Azithromycin. It has been shown in a newspaper that it lowers the risk in people who have viral infections. And the other reason is that Azithromycin has shown in the laboratory that it is effective against a large number of viruses, although it is an antibiotic. So even choosing an antibiotic, we preferred to take an antibiotic effective against viruses. And when we compare the percentage of positives with the hydroxychloroquine and Azithromycin combination,
The results of the first clinical tests carried out with hydroxychloroquine and azithromycin.
The results of the first clinical tests carried out with hydroxychloroquine and azithromycin. - IHU screenshot
For Professor Didier Raoult, this viral port is at the center of the fight against the coronavirus. He cites a Chinese study published on March 9. “There is one very important thing in this retrospective study: the length of the viral carriage is an essential element in trying to control this disease. It shows that the people who carry the virus, we are talking about 191 people, carry it for twenty days if they are not treated. So the people who invented the fortnight, it doesn't make sense. We must isolate people who are carriers, and not isolate non-carriers. This is a very important point, ”said the specialist.
The Chinese study on the duration of carriage of the virus.
The Chinese study on the duration of carriage of the virus. - IHU screenshot
More tests
But to reduce this viral carry, it is necessary to test a maximum of people. Which is not the government's current strategy. "How was AIDS mastered? It is neither through vaccines, nor through mathematical models. It is the viral load and the treatment, we watch with the treatment that the viral load decreases and, when it is below a certain threshold, people are no longer contagious and are no longer sick. It is this model that we are trying to set up. But in this strategy, we test, we detect, we treat, the world is not equal. Those who run the fastest are not the same, those who did the most are the Chinese and Korea. For a population smaller than ours, look at the number of tests they have done. We took a strategy which is not the same as that of the technological world, it is very little to test. "